Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y. Nakamoto

Tobramycin Inactivation by Carbenicillin, Ticarcillin, and Piperacillin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1983English

Related publications

Tobramycin Inactivation by Carbenicillin, Ticarcillin, and Piperacillin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1983English

Comparison of in Vitro Activity of Moxalactam (LY127935) With Cefazolin, Amikacin, Tobramycin, Carbenicillin, Piperacillin, and Ticarcillin Against 420 Blood Culture Isolates.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1980English

Comparative Efficacies of Piperacillin, Azlocillin, Ticarcillin, Aztreonam, and Tobramycin Against Experimental Pseudomonas Aeruginosa Pneumonia.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1984English

Gentamicin Inactivation by Piperacillin or Carbenicillin in Patients With End-Stage Renal Disease.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1982English

Comparative Activities of Ciprofloxacin, Ticarcillin, and Tobramycin Against Experimental Pseudomonas Aeruginosa Pneumonia.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1984English

Susceptibility of Pseudomonas Aeruginosa to Tobramycin or Gentamicin Alone and Combined With Carbenicillin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1975English

Comparative in Vitro Activity of LY127935(6059-S), Seven Cephalosporins, Three Aminoglycosides, Carbenicillin, and Ticarcillin.

Journal of Antibiotics
Drug DiscoveryPharmacology
1979English

Effect of Applying the New Clinical and Laboratory Standards Institute Ticarcillin/Clavulanic Acid, Piperacillin, Piperacillin/Tazobactam and Imipenem Susceptibility Breakpoints for Pseudomonas Aeruginosa in Hong Kong

International Journal of Antimicrobial Agents
MedicineInfectious DiseasesMicrobiologyPharmacology
2012English

In Vitro Susceptibilities of 393 Recent Clinical Isolates to WIN 49375, Cefotaxime, Tobramycin, and Piperacillin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1984English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy